Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-01 Sale |
2023-05-02 4:33 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
342 | $9.8763 | $3,378 | 16,695 (Direct) |
View |
| 2023-01-30 Sale |
2023-02-01 4:18 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
424 | $11.78 | $4,995 | 15,484 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-01 7:32 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
350 | $12.88 | $4,508 | 15,908 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 5:48 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
356 | $15.67 | $5,579 | 14,706 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:04 pm |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
330 | $11.75 | $3,878 | 15,062 (Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 9:52 pm |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
5,504 | $60.75 | $334,385 | 19,096 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-09 Option Award |
2023-08-11 9:09 pm |
N/A 2033-08-09 |
Rain Oncology Inc. | RAIN | Wolff Stefani Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-04-30 Exercise |
2023-05-02 4:33 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 16,695 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-15 4:14 pm |
N/A 2033-02-13 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
112,900 | $0 | 112,900 (Direct) |
View |
| 2023-01-30 Exercise |
2023-02-01 4:18 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 15,484 (Direct) |
View |
| 2022-10-30 Exercise |
2022-11-01 7:32 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 15,908 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:38 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Wolff Stefani Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-10 4:18 pm |
N/A 2032-08-08 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
110,375 | $0 | 110,375 (Direct) |
View |
| 2022-07-30 Exercise |
2022-08-02 5:48 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 14,706 (Direct) |
View |
| 2022-04-30 Exercise |
2022-05-03 7:04 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
962 | $0 | 15,062 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:17 pm |
N/A 2032-01-18 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
50,023 | $0 | 50,023 (Direct) |
View |
Ownership |
2021-08-17 5:19 pm |
N/A 2031-07-12 |
Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO |
0 | $0 | 443,865 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 5:44 pm |
N/A 2031-05-14 |
Rain Therapeutics Inc. | RAIN | Wolff Stefani Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2020-09-18 Gift |
2020-09-28 5:19 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
5,504 | $0 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:19 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
13,592 | $100 | 0 (Direct) |
View |